Editas Medicine, Inc.
$3.16
-0.14 (-4.24%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +17.5%
- 3 Months
- -8.7%
- YTD
- +54.1%
- 1 Year
- +18.4%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 84.6%
- Largest decline max drawdown, since Aug 2025
- -59.9%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.62
Own EDIT?
See how EDIT contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.